Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin D Funk

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 10, 2008
Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transportMichael P W Moos, Jeffrey D Mewburn, Frederick W K Kan, et al.
Journal of the American Heart Association|April 8, 2015
Endogenously generated omega-3 fatty acids attenuate vascular inflammation and neointimal hyperplasia by interaction with free fatty acid receptor 4 in miceXinzhi Li, Laurel L Ballantyne, Xinghui Che, et al.
Plos One|May 5, 2015
Strategies to rescue the consequences of inducible arginase-1 deficiency in miceLaurel L Ballantyne, Yuan Yan Sin, Tim St Amand, et al.
The American Journal of Pathology|March 4, 2005
Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout micePeter B Anning, Barbara Coles, Alexandra Bermudez-Fajardo, et al.
Circulation Research|April 19, 2013
Cyclooxygenase-2-derived prostaglandin E₂ promotes injury-induced vascular neointimal hyperplasia through the E-prostanoid 3 receptorJian Zhang, Fangfang Zou, Juan Tang, et al.
Science Translational Medicine|May 4, 2012
Vascular COX-2 modulates blood pressure and thrombosis in miceYing Yu, Emanuela Ricciotti, Rosario Scalia, et al.
Archives of Biochemistry and Biophysics|February 1, 2014
A mutation interfering with 5-lipoxygenase domain interaction leads to increased enzyme activityMarija Rakonjac Ryge, Michiharu Tanabe, Patrick Provost, et al.
Hepatology (Baltimore, Md.)|October 23, 2010
Disruption of the 12/15-lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver diseaseMarcos Martínez-Clemente, Natàlia Ferré, Esther Titos, et al.
The American Journal of Pathology|May 19, 2012
Prostaglandin receptor EP4 in abdominal aortic aneurysmsRichard Y Cao, Tim St Amand, XinZhi Li, et al.
Hepatology (Baltimore, Md.)|January 30, 2010
5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null miceMarcos Martínez-Clemente, Natàlia Ferré, Ana González-Périz, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 10, 2008
Cysteinyl leukotriene 2 receptor-mediated vascular permeability via transendothelial vesicle transportMichael P W Moos, Jeffrey D Mewburn, Frederick W K Kan, et al.
Journal of the American Heart Association|April 8, 2015
Endogenously generated omega-3 fatty acids attenuate vascular inflammation and neointimal hyperplasia by interaction with free fatty acid receptor 4 in miceXinzhi Li, Laurel L Ballantyne, Xinghui Che, et al.
Plos One|May 5, 2015
Strategies to rescue the consequences of inducible arginase-1 deficiency in miceLaurel L Ballantyne, Yuan Yan Sin, Tim St Amand, et al.
The American Journal of Pathology|March 4, 2005
Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout micePeter B Anning, Barbara Coles, Alexandra Bermudez-Fajardo, et al.
Circulation Research|April 19, 2013
Cyclooxygenase-2-derived prostaglandin E₂ promotes injury-induced vascular neointimal hyperplasia through the E-prostanoid 3 receptorJian Zhang, Fangfang Zou, Juan Tang, et al.
Science Translational Medicine|May 4, 2012
Vascular COX-2 modulates blood pressure and thrombosis in miceYing Yu, Emanuela Ricciotti, Rosario Scalia, et al.
Archives of Biochemistry and Biophysics|February 1, 2014
A mutation interfering with 5-lipoxygenase domain interaction leads to increased enzyme activityMarija Rakonjac Ryge, Michiharu Tanabe, Patrick Provost, et al.
Hepatology (Baltimore, Md.)|October 23, 2010
Disruption of the 12/15-lipoxygenase gene (Alox15) protects hyperlipidemic mice from nonalcoholic fatty liver diseaseMarcos Martínez-Clemente, Natàlia Ferré, Esther Titos, et al.
The American Journal of Pathology|May 19, 2012
Prostaglandin receptor EP4 in abdominal aortic aneurysmsRichard Y Cao, Tim St Amand, XinZhi Li, et al.
Hepatology (Baltimore, Md.)|January 30, 2010
5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null miceMarcos Martínez-Clemente, Natàlia Ferré, Ana González-Périz, et al.
Pageof 10